Featured
BOSTON // October 5, 2023: Medisafe, an industry-leading digital health company specializing in medication management, is pleased to announce it is now working with Amazon Web Services (AWS) to utilize Medisafe’s 10+ years of experience and healthcare data and AWS’s artificial intelligence (AI) capabilities to build the future of connected health. For more than a…
Read More
BOSTON –September 21, 2023 – With strategic brand planning season in full swing, Medisafe, a leading digital health company specializing in medication management, is announcing the launch of Rapid Release – an accelerated offering that launches a configurable and scalable Digital Companion on our Connected Health Platform in 90 days or less. Rapid Release enables…
Read More
BOSTON, MA / ACCESSWIRE / September6, 2023 / Medisafe, a leading digital health company specializing in medication engagement, released the results of a new retrospective, pre and post claims study of 207 patients with multiple sclerosis (MS) and epilepsy using Medisafe to manage their medication regimen and overall health. The analysis showed an average annual…
Read More
At Medisafe, our mission is to support better overall health management by connecting our customers with the technology they need to enhance their patients’ experience and improve outcomes. Our Connected Health platform was designed to do just that, by enabling our customers with tools to fill gaps in the care they provide and expanding their…
Read More
BOSTON, Jan. 4, 2023 — Medisafe, a leading digital therapeutics company specializing in medication engagement, is pleased to announce its Software as a Medical Device (SaMD) technology. This announcement comes just months after achieving ISO 13485:2016 certification, meeting quality management system parameters specific to medical devices, as well as ISO 27001:2013 certification, meeting IT security management system…
Read More
New survey finds patients are seeking support for social determinants of health in managing their complete health BOSTON – October 25, 2022 – A new survey of more than 2,000 patients by leading digital therapeutics company Medisafe shows receiving support for mental health conditions is the biggest challenge among nearly all patient segments. The survey…
Read More
Medisafe has been selected as a finalist in the Most Valuable Digital Therapy for Pharma category in the Reuters Pharma Awards 2022. Medisafe was selected among over 700 submissions due to its innovative approach to medication management and joins the ranks of other leading pharma organizations including Sanofi, Merck, Biogen, Takeda, and others in this…
Read More
BOSTON, September 7, 2022 – Medisafe, the leading medication engagement company, today announced that it has achieved the ISO 13485:2016 certification which supports the design and development of Software as a Medical Device (SaMD) used for the diagnosis, prognosis, or prediction of disease progression. Achieving this new certification serves as third-party industry validation that Medisafe…
Read More
By Omri Shor Co-Founder and CEO Medisafe 10 YEARS. Celebrating a decade of Medisafe® is about more than just thriving in a highly competitive industry. Our mission has always been to help improve the lives of patients, and over the past 10 years we have helped more than 10 MILLION PATIENTS who rely on Medisafe…
Read More
Monitoring medication is one of the defining responsibilities of a caregiver, according to a new survey conducted from April 6 – 25, 2022 by Medisafe, the leading medication engagement platform Here’s what more than 3000 U.S. patients using Medisafe’s platform had to say:
Read More